Telix Pharmaceuticals Ltd reported 29.84M in Selling and Administration Expenses for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Cochlear COH:AU $ 301.9M 9.6M
CSL CSL:AU $ 1.03B 5.6M
Integral Diagnostics Ltd IDX:AU 115.48M 3.63M
Mayne Pharma MYX:AU $ 72.41M 22.59M
Opthea Ltd OPT:AU 10.53M 2.4M
Pacific Edge PEB:NZ 15.39M 2.24M
Paradigm Biopharmaceuticals Ltd PAR:AU 4.2M 1.61M
Polynovo Ltd PNV:AU 12.33M 2.93M
PYC Therapeutics Ltd PYC:AU 1.05M 6.78M
Ramsay Health Care RHC:AU $ 3.96B 9.5M
ResMed RMD:AU $ 282.41M 100.01M
Sonic Healthcare SHL:AU $ 2.07B 70.56M